Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I

Fredrickson, 1961, Tangier disease—combined clinical staff conference at the National Institutes of Health, Ann. Intern. Med., 55, 1016, 10.7326/0003-4819-55-6-1016 Assmann, 1995, Familial HDL deficiency. Tangier disease, 2053 von Eckardstein, 1995, Reverse cholesterol transport in plasmas of patients with different forms of familial high density lipoprotein deficiency, Arterioscler. Thromb. Vasc. Biol., 15, 691, 10.1161/01.ATV.15.5.691 Fielding, 1995, Molecular physiology of reverse cholesterol transport, J. Lipid Res., 36, 211, 10.1016/S0022-2275(20)39898-9 von Eckardstein, 1996, Cholesterol efflux from macrophages and other cells, Curr. Opin. Lipidol., 7, 308, 10.1097/00041433-199610000-00009 Oram, 1997, Apolipoprotein-mediated removal of cellular cholesterol and phospholipids, J. Lipid Res., 37, 2473, 10.1016/S0022-2275(20)37453-8 Castro, 1988, Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein, Biochemistry., 27, 25, 10.1021/bi00401a005 Huang, 1993, Cell-derived cholesterol cycles between different HDLs and LDL for its effective esterification in plasma, Arterioscler. Thromb., 13, 445, 10.1161/01.ATV.13.3.445 Kawano, 1993, Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid, Biochemistry., 32, 5025, 10.1021/bi00070a008 Hara, 1991, Interaction of free apolipoproteins with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol, J. Biol. Chem., 266, 3080, 10.1016/S0021-9258(18)49957-7 Czarnecka, 1995, Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux, Biochemistry., 34, 4385, 10.1021/bi00013a030 Czarnecka, 1996, Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange, J. Biol. Chem., 266, 2023, 10.1074/jbc.271.4.2023 Yancey, 1995, Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides, Biochemistry., 34, 7955, 10.1021/bi00024a021 Li, 1995, Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells, J. Biol. Chem., 269, 26216, 10.1074/jbc.270.44.26216 Mendez, 1991, Protein kinase C as a mediator of high density lipoprotein dependent efflux of intracellular cholesterol, J. Biol. Chem., 266, 10104, 10.1016/S0021-9258(18)99196-9 Walter, 1995, HDL3 stimulates multiple signaling pathways in human skin fibroblasts, Arterioscler. Thromb. Vasc. Biol., 15, 1975, 10.1161/01.ATV.15.11.1975 Francis, 1995, Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease, J. Clin. Invest., 96, 78, 10.1172/JCI118082 Remaley, 1997, Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux, Arterioscler. Thromb. Vasc. Biol., 17, 1813, 10.1161/01.ATV.17.9.1813 Huang, 1995, Generation of preβ1-high density lipoprotein (HDL) and conversion into α-HDL: evidence for disturbed preβ1-HDL conversion in Tangier disease, Arterioscler. Thromb. Vasc. Biol., 15, 1746, 10.1161/01.ATV.15.10.1746 Barrans, 1996, Pre-β HDL: structure and metabolism, Biochim. Biophys. Acta., 1300, 73, 10.1016/0005-2760(95)00236-7 Davidson, 1994, The molecular basis for the difference of charge between preβ- and α-migrating high density lipoproteins, J. Biol. Chem., 269, 8959, 10.1016/S0021-9258(17)37061-8 Sparks, 1993, Effect of cholesterol on the charge and structure of apolipoprotein A-I in high density lipoprotein particles, J. Biol. Chem., 268, 23250, 10.1016/S0021-9258(19)49456-8 Jaspard, 1996, Biochemical characterization of pre β1-high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core, Biochemistry., 35, 1352, 10.1021/bi950938i Assmann, 1977, The lipoprotein abnormality in Tangier disease. Quantitation of A apoproteins, J. Clin. Invest., 59, 565, 10.1172/JCI108672 Gibbels, 1985, Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies, J. Neurol., 232, 283, 10.1007/BF00313867 Römling, 1994, A nonsense mutation in the apolipoprotein A-I gene is associated with high density lipoprotein deficiency but not with coronary artery disease, Arterioscler. Thromb., 14, 1915, 10.1161/01.ATV.14.12.1915 Navalesi, 1995, Genetically determined absence of HDL-cholesterol and coronary atherosclerosis (letter), Lancet., 346, 708, 10.1016/S0140-6736(95)92323-3 Miccoli, 1996, Hemizygosity for a structural apolipoprotein A-I-variant, apoA-I(L141R)Pisa, causes high density lipoprotein deficiency, corneal opacifications, and coronary heart disease, Circulation., 94, 1622, 10.1161/01.CIR.94.7.1622 Walter, 1996, Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms, J. Clin. Invest., 98, 2315, 10.1172/JCI119043 Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182 von Eckardstein, 1994, Sex-specific effects of the glutamine/histidine polymorphism in apolipoprotein A-IV on high density lipoprotein metabolism, Arterioscler. Thromb., 14, 1114, 10.1161/01.ATV.14.7.1114 von Eckardstein, 1991, Site specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity in apolipoproteins A-I, C-II, and C-III, J. Lipid Res., 32, 1465, 10.1016/S0022-2275(20)41914-5 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (Lond)., 227, 680, 10.1038/227680a0 Pritchard, 1988, Lecithin:cholesterol acyltransferase in familial HDL-deficiency, Biochim. Biophys. Acta., 958, 227, 10.1016/0005-2760(88)90181-6 Kato, 1989, Purification, microheterogeneity, and stability of human lipid transfer protein, J. Biol. Chem., 264, 4082, 10.1016/S0021-9258(19)84965-7 Jauhiainen, 1993, Human plasma phospholipid transfer protein causes high density lipoprotein conversion, J. Biol. Chem., 268, 4032, 10.1016/S0021-9258(18)53575-4 Matz, 1982, Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate–lipid dispersions, J. Biol. Chem., 257, 4535, 10.1016/S0021-9258(18)34756-2 Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Tall, 1995, Plasma lipid transfer enzymes, Annu. Rev. Biochem., 64, 235, 10.1146/annurev.bi.64.070195.001315 Albers, 1996, Molecular biology of phospholipid transfer protein, Curr. Opin. Lipidol., 7, 88, 10.1097/00041433-199604000-00007 Wirtz, 1991, Phospholipid transfer enzymes, Annu. Rev. Biochem., 60, 73, 10.1146/annurev.bi.60.070191.000445 Alb, 1996, Phospholipid metabolism and membrane dynamics, Curr. Opin. Cell Biol., 8, 534, 10.1016/S0955-0674(96)80032-9 Hennessy, 1993, Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of preβ-high density lipoprotein particles, Biochemistry., 32, 5759, 10.1021/bi00073a006 Liang, 1994, Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins, J. Lipid Res., 35, 1187, 10.1016/S0022-2275(20)39962-4 Liang, 1995, Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools, Biochim. Biophys. Acta., 1257, 31, 10.1016/0005-2760(95)00055-H Francone, 1996, Increased preβ-HDL levels, cholesterol efflux, and LCAT mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes, J. Lipid Res., 37, 1268, 10.1016/S0022-2275(20)39156-2 von Eckardstein, 1996, Phospholipid transfer protein-mediated conversion of high density lipoproteins (HDL) generates generation of preβ1-HDL, Biochim. Biophys. Acta., 1301, 255, 10.1016/0005-2760(96)00050-1 Jiang, 1996, Increased preβ-high density lipoprotein, apolipoprotein A-I, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein A-I transgenes, J. Clin. Invest., 98, 2373, 10.1172/JCI119050 Clay, 1996, Formation of new HDL particles from lipid-free apolipoprotein A-I, J. Lipid Res., 37, 1722, 10.1016/S0022-2275(20)39115-X Liang, 1996, Remodelling of reconstituted high density lipoproteins by lecithin:cholesterol acyltransferase, J. Lipid Res., 37, 1962, 10.1016/S0022-2275(20)37561-1 Wurfel, 1997, Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid, J. Immunol., 158, 3925, 10.4049/jimmunol.158.8.3925 Yu, 1997, Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids, J. Clin. Invest., 99, 315, 10.1172/JCI119160 Reinhart, 1989, Haemolytic anaemia, in analphalipoproteinaemia (Tangier disease): morphological, biochemical, and biophysical properties of the red blood cell, Br. J. Haematol., 72, 272, 10.1111/j.1365-2141.1989.tb07694.x Drobnik, 1995, Activation of phosphatidylinositol-specific phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients, Arterioscler. Thromb. Vasc. Biol., 15, 1369, 10.1161/01.ATV.15.9.1369